Loading video...

Video Failed to Load

Go Home

GI Pathology 101! For each subsite, we go through path basics – histology, IHC & molecular markers, key features from resection specimen & more. I ask Suntrea Hammer to explain path slides to me like I’m a 5-year-old 😀 Here's Part 1: CRC Full video link & slides below🧵1/4:

13,723 views • 1 year ago •via X (Twitter)

8 Comments

Dr. Nina Niu Sanford's profile picture
Dr. Nina Niu Sanford1 year ago

YouTube link 2/4:

Dr. Nina Niu Sanford's profile picture
Dr. Nina Niu Sanford1 year ago

Slides 3/4:

Dr. Nina Niu Sanford's profile picture
Dr. Nina Niu Sanford1 year ago

Mores slides 4/4. Though much more helpful to listen to Suntrea explain the histo: Other subsites coming soon, let me know any feedback.

Raffaele Di Giacomo, PhD's profile picture
Raffaele Di Giacomo, PhD1 year ago

Dr. Sanford, your approach to breaking down GI pathology is highly commendable! Understanding histology, IHC, and molecular markers is crucial for accurate diagnosis and treatment planning. A question for @SuntreaHammer: what do you consider the most challenging aspect when explaining molecular markers to a non-specialist? For anyone interested in deepening their knowledge or seeking more detailed reviews on topics like these, I recommend It’s a one-stop platform answering every biomedical question and generating comprehensive reviews. #Medicine #Gastroenterology

Erman Akkus's profile picture
Erman Akkus1 year ago

❓Adjuvant/perioperative chemotherapy for curative liver metastesectomy of CRC? @myESMO #ESMOGI25 ✅Probably DFS but no OS benefit ✅decision should be individualized ❓ctDNA? 👉 #cancer #oncology #MedX #CRC @OncoAlert @realbowtiedoc

Mario Balsa's profile picture
Mario Balsa1 year ago

🆕 Final analysis of SURF-RCT/SURF-Cohort for small HCC just dropped in @JCO_ASCO: surgery vs RFA ⚔️ 🎯 5-yr OS: 74.6% (S) vs 70.4% (RFA) 🎯 5-yr RFS: 42.9% (S) vs 42.7% (RFA) 💥 AEs: 3.3% (S) vs 0% (RFA) Sometimes, less is more — and the probe wins again ⚖️ Congrats to @YoKawaguchiUT and all the team! 👏🏼 @OncoAlert #OncoAlertAF @_SEOM @GrupoTTD

Neil Iyengar, MD's profile picture
Neil Iyengar, MD1 year ago

I am delighted to join @WinshipAtEmory as co-director of breast oncology and director of cancer survivorship. Excited to join this team with deep and synergistic expertise where we will continue advancing cutting-edge science at the intersection of metabolic health and cancer!

Stephen V Liu, MD's profile picture
Stephen V Liu, MD1 year ago

Make plans for #DCLung25 - Saturday, October 4th - Washington DC - a one-day @IASLC endorsed comprehensive lung cancer conference! Dr. Marina Garassino @marinagarassino joins with the latest updates in immunotherapy for NSCLC. Register today!

Related Videos